Chlamydia testing up 10% in England – “Screening efforts must be maintained”
This article was originally published in Clinica
The latest UK data on sexually-transmitted infections (STIs), featuring falls in the number of new cases and a significant rise in chlamydia testing, are encouraging but “prevention efforts, including greater screening coverage should be sustained”.
You may also be interested in...
South Korea’s HLB has begun a new growth phase by taking over US-based clinical stage biotech firm Immunomic Therapeutics. Through the acquisition, it is poised to add new pipeline assets including a Phase II vaccine therapy for glioblastoma and proprietary lysosomal targeting technology.
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.